Aiding the Drivers of Economic Growth 
Carlos M. Gutierrez, U.S. Secretary of Commerce, says that we need new benchmarks for a
fuller understanding of the impact of innovation, and to help both government
and businesses identify and devise innovation-promoting policies that create
value and growth.
Berkeley Center for Law and Technology and the Berkeley Technology Law Journal hold 12th Annual Symposium
Berkeley Center for Law and Technology (BCLT) and the Berkeley Technology Law Journal (BTLJ) will hold its Symposium on Intellectual Property and Entrepreneurship March 7-8, 2008 at the University of California, Berkeley, School of Law.
Effects of Patent Reforms on Entrepreneurs
The Federal Trade Commission (FTC) and the National Academy of Sciences (NAS)
are among the many institutions calling for reform of the U.S. patent system
because it no longer promotes innovation and competition as well as it should.
Innovation that Matters
Nicholas Donofrio, Kauffman Senior Fellow and retired executive vice president of Innovation and Technology, IBM, believes the innovations that matter now are the ones that unlock the hidden value that exists at the intersection of deep knowledge of a problem and intimate knowledge of a market.
Intellectual Property, the Immigration Backlog, and a Reverse Brain-Drain
More than one million skilled immigrant workers, including scientists,
engineers, doctors and researchers and their families, are competing
for 120,000 permanent U.S. resident visas each year, creating a
sizeable imbalance likely to fuel a "reverse brain-drain" with skilled
workers returning to their home country, according to a new report
released by the Kauffman Foundation.
International Think Tank to Discuss the Development of High-Growth Businesses and Ties to Innovation & Intellectual Assets
An economic development organization representing 30 nations including the United States is holding an international workshop in Kansas City on innovation and the global impact of high-growth small- and medium-sized enterprises (SMEs).
The Distributed Partnering Model for Drug Discovery and Development
The major contributors to therapeutic innovations in the 20th century have been the pharmaceutical companies, with biotechnology companies adding significantly over the last twenty-five years. However, these models increasingly have failed in translating the advances of biomedical sciences into innovative products. We suggest a modern-day paradigm for efficiently advancing new therapeutic products.
The Entrepreneurial Landscape: A View from Venture Partners
Kauffman Foundation Chief Investment Officer Harold Bradley moderates a panel with investment leaders from three established and respected venture
capital firms to discuss a number of issues facing the venture industry.
